Reform of Prescription Drug Reimbursement and Pricing in the German Social Health Insurance Market: A Comparison of Three Scenarios

Author： Greß Stefan  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.6, 2007-01, pp. : 443-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A lack of prescription drug insurance is the most common barrier to prescription drug access for elderly individuals in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 410, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

US health insurance reform becomes law

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 600, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

US moves a step closer to health insurance reform

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 591, 2009-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Prescription Drug Abuse: A Comparison of Prescriber and Pharmacist Perspectives

By Hagemeier Nicholas E.  

Substance Use & Misuse, Vol. 48, Iss. 9, 2013-06 ,pp. : 761-768

Informa Healthcare

Access to resources Recommend Favorite

Drug pricing and control of health expenditures: a comparison between a proportional decision rule and a cost‐per‐QALY rule

By  

International Journal Of Health Planning And Management, Vol. 30, Iss. 4, 2015-10 ,pp. : 395-402

John Wiley & Sons Inc

Access to resources Recommend Favorite